North America Needle Biopsy Market – Industry Trends and Forecast to 2028

Market Analysis and Insights: North America Needle Biopsy Market

North America needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2021 to 2028 and is expected to reach USD 805.76 million by 2028 from USD 467.72 million in 2020.

A needle biopsy is a manual, image-guided or ultrasound procedure, which is used to obtain a sample of cells, from the human body for laboratory or diagnostic testing, especially of the tumour. The common needle biopsy procedures include fine-needle aspiration biopsy and core needle biopsy. When a doctor identifies an abnormal lump, or when the imaging scans show, the presence of abnormalities in the body, then the use of needle biopsies needle biopsy comes in place. The needle biopsies needle biopsy is regularly used to detect and diagnose breast cancer. Lung cancer and other types of cancer, but it is also used to find an infection, match the organ tissues, before a transplant and finding the nerve damage are also used to find an infection, match the organ tissues, match the organ tissues before a transplant, and find the nerve damage in the human body.

There are four different types of needle biopsies. The fine fine-needle aspiration biopsy uses a thin needle which that is several inches long. The syringe is implemented to extract the cells, tissues, and fluids. A wide hollow needle which extracts the pieces of the tissue from the area of examination is used by the core needle biopsy. Using a real time image, the image-guided biopsy, the doctor would be able to guide the needle into the best position for obtaining a sample of suspicious cells. It allows the doctor to detect suspicious areas that aren't readily seen or felt through the skin of the individual’s skin such as the prostate gland, thyroid gland, gastrointestinal gland. The vacuum assisted needle biopsy utilizes a hollow introducer, which is positioned into place with imaging guidance.

The increase in prevalence of lung, prostate and breast cancer, rise in government initiatives for awareness about treatment of lung, prostate and breast cancer and increased demand for minimally invasive surgeries pave the way for the growth of needle biopsies market. Moreover, the strategic initiatives by market players and growth potential in emerging economies for needle biopsy and rise in product approvals bolster the needle biopsy market growth. However the rise in cost of needle biopsies the stringent regulations imposed and the needle biopsy being inaccessible to developing countries are the restraints which can hinder the market growth. The side effects incurred while using needle biopsies in the material used are the restraints which can hinder the market growth.

The needle biopsy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Needle Biopsy Market Scope and Market Size

Needle biopsy market is segmented on the basis of needle type, ergonomics procedure, sample site, utility, application, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of needle type, the needle biopsy market is segmented into trephine biopsy needles, klima sternal needle, salah needle aspiration needle, jamshidi needle and others. In 2021, the trephine biopsy needles segment is expected to dominate dominating the needle biopsies needle biopsy market due to its overall assessment of morphology and being used as an alternative to fine needle biopsy are predicted to dominate the market.
• On the basis of ergonomics, the needle biopsy market is segmented into sharp, blunt, quincke, chiba, franseen and others. In 2021 the sharp segment is expected to dominate the needle biopsies needle biopsy market due owing to its accurate precision of detection and diagnosis of the cancer tumor.
• On the basis of procedure, the needle biopsy market is segmented into fine- needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy. In 2021, the fine- needle aspiration biopsy segment is expected to dominate the needle biopsy market since it’s minimally invasive, provides rapid and effective diagnostic result. It provides rapid and effective diagnostic results to determine the status of the suspected tissue and timely diagnosis and treatment are predicted to dominate the market.
• On the basis of sample site, the needle biopsy market is segmented into muscles, bones and other organs. In 2021, the muscle segment is expected to dominate the needle biopsies needle biopsy market, since it provides the source of the disease process and better diagnostic approaches are predicted to dominate the market.
• On the basis of utility, the needle biopsy market is segmented into disposable and reusable. In 2021, the disposable segment is expected to dominate is dominating the needle biopsy market, since the needle biopsy can be used once and disposed of carefully and the chances of infection are less are predicted to dominate the market.
• On the basis of application, the needle biopsy market is segmented into tumour, infection, inflammation and others. In 2021, the tumour segment is expected to dominate the needle biopsy market due to increased cases of malignant tumour the needle biopsy market due to increased malignant tumour cases in breast cancer and lung cancer and ease of localization and detection.
• On the basis of end user, the needle biopsies needle biopsy market is segmented into hospitals, diagnostic centres, biopsy labs, ambulatory surgical centres, academic and research organizations and others. In 2021, the hospitals segment is expected to dominate the needle biopsy market due to the increased need for treatment of cancer and the availability of needle biopsies needle biopsy are predicted to dominate the market.
• On the basis of distribution channel, the needle biopsies needle biopsy market is segmented into direct tender, retail sales. In 2021, direct tender segment is expected to dominate the needle biopsy market due to the rise in access to fine fine-needle aspiration biopsies, surge in a number of biopsies on a daily basis and rise in a number of contacts for the supply of diagnostic medications and needle biopsies needle biopsy are predicted to dominate the market.

North America Needle Biopsy Market Country Level Analysis

The needle biopsy market is analysed and market size information is provided by needle type, ergonomics procedure, sample site, utility, application, end user and distribution channel as referenced above.

The countries covered in the North America needle biopsy market report are the U.S., Canada and Mexico.

• In 2021, the U.S. is expected to dominate due to increased cases of various types of cancer, maximum use and purchase of bone biopsy needles and the presence of the largest consumer market with high GDP. Moreover, the U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth Potential for Needle Biopsy in Emerging Economies and the Strategic Initiatives by Market Players are creating new Opportunities in the North America Needle Biopsy Market

Needle biopsy market also provides you with detailed market analysis for every country growth in particular industry with needle biopsy sales, impact of advancement in the needle biopsy and changes in regulatory scenarios with their support for the needle biopsy market. The data is available for historic period 2010 to 2019.

Competitive Landscape and North America Needle Biopsy Market Share Analysis

North America needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the needle biopsy market.

The major companies providing the needle biopsy are, Boston Scientific Corporation, Hologic, Inc., AprioMed AB, Amecath, Zamar Care, Cardinal Health., INRAD, Inc., BD, Möller Medical GmbH, ARGON MEDICAL, Merit Medical Systems, PAJUNK, B. Braun Melsungen AG among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for North America needle biopsy are bridging the gap for treatment of needle biopsy market.

For instance,

• In May 2014, Boston Scientific Corporation organized the World Class Endoscopy Training at its Paris Institute for Advanced Sciences. The training created awareness about the use of endoscopy and its practice in the medical community in Paris. The educational training delivered had resulted in creating awareness about the use of needle biopsy in endoscopy

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the needle biopsy market which also provides the benefit for organisation to improve their offering for North America needle biopsy market.

SKU-64212